Virual Oral Presentation Slide by Slide

IEEE/ICACT20260263 Slide.21        [Big Slide]	Oral Presentation
	Our current limitations include coverage of only three CYP enzymes, use of static structures without dynamics, no metabolite structure prediction, and limited clinical outcome validation. Future work includes expanding to all drug-metabolizing CYPs, integrating molecular dynamics for flexibility, developing reaction mechanism prediction, and deploying a clinical decision support prototype with pharmaceutical partners. Long-term, we envision a comprehensive precision medicine platform.

[Go to Next Slide]

Select Voice: Virtual Oral Presentation!!